Table 2 Medians with the first and third quartiles in parentheses and ranges in brackets of the nine parameters, in the malignant (A), benign (B) and transudates (C) group, respectively.

14.0 (11.0–20.7), [4.0–52.6]

15.9 (9.3–23.7), [5.9–59.7]

4.9 (3.9–7.2), [3.3–8.4]

0.004

AvsB p = 0.582; AvsC p < 0.001; BvsC p = 0.001

8.7 (7.2–11.2), [2.3–23.0]

6.6 (5.1–7.7), [3.3–9.9]

8.6 (6.6–13.0), [5.5–16.4]

0.007

AvsB p = 0.002; AvsC p = 0.983; BvsC p = 0.059

1.7 (1.1–2.5), [0.5–4.3]

2.3 (1.3–5.0), [0.9–8.6]

0.5 (0.3–1.1), [0.3–1.1]

0.003

AvsB p = 0.059; AvsC p = 0.004; BvsC p = 0.001

4.2 (3.4–5.2), [1.6–6.1]

4.3 (3.6–4.8), [3.0–5.2]

2.6 (2.1–2.7), [1.6–2.8]

0.003

AvsB p = 0.930; AvsC p = 0.001; BvsC p < 0.001

6.3 (5.7–7.2), [4.7–8.6]

6.6 (6.1–7.1), [5.3–7.9]

6.3 (5.0–6.7), [4.8–7.0]

0.444

AvsB p = 0.607; AvsC p = 0.350; BvsC p = 0.173

0.6 (0.6–0.7), [0.3–2.0]

0.6 (0.6–0.7), [0.5–2.0]

0.4 (0.3–0.5), [0.2–0.5]

0.009

AvsB p = 0.920; AvsC p = 0.002; BvsC p = 0.001

333.5 (207.0–666.2), [74–7000]

242.0 (144.0–521.0), [73–677]

103.0 (66.5–144.5), [63–177]

0.004

AvsB p = 0.215; AvsC p < 0.001; BvsC p = 0.014

256.0 (204.2–366.0), [163–1018]

201.0 (165.5–253.0), [129–309]

262.0 (237.0–267.5), [214–272]

0.056

AvsB p = 0.210; AvsC p = 0.914; BvsC p = 0.117

1.2 (0.8–1.8), [0.3–9.5]

1.4 (0.6–2.8), [0.4–3.2]

0.4 (0.3–1.00), [0.2–0.7]

0.008

AvsB p = 0.773; AvsC p = 0.001; BvsC p = 0.004